Press Release

United Kingdom Molecular Diagnostics Market to be Dominated by Reagents Segment Through 2028

Increasing demand for genetic testing and expanding diagnostic technologies are expected to drive the United Kingdom Molecular Diagnostics Market in the forecast period, 2024-2028.

 

According to TechSci Research report, “United Kingdom Molecular Diagnostics Market – By Region, Competition Forecast and Opportunities, 2018-2028F,” the United Kingdom Molecular Diagnostics Market is anticipated to grow at a significant rate in the forecast period, f 2024-2028. The molecular diagnostics market in the United Kingdom is witnessing significant growth, driven by the increasing prevalence of chronic diseases among the rising geriatric population. One of the main reasons the geriatric population is driving the molecular diagnostics market is the higher incidence of age-related diseases. As people age, they become more susceptible to various health conditions such as cancer, cardiovascular diseases, neurological disorders, and infectious diseases. Molecular diagnostics offer precise and early detection of these conditions, allowing for timely intervention and personalized treatment plans. The ability to detect diseases at their molecular level enables healthcare providers to tailor therapies and medications specifically to each patient, improving overall outcomes. With advancements in technology, there has been a notable increase in public awareness regarding the role of genetics in disease susceptibility. Individuals are becoming more conscious of the potential genetic factors contributing to various conditions, including cancer, cardiovascular diseases, and rare genetic disorders. This heightened awareness has prompted more people to seek genetic testing as a means of gaining valuable insights into their risk profiles, facilitating early detection, and enabling proactive healthcare management, which is expected to propel the growth of the United Kingdom Molecular Diagnostics Market in the forecast period.

However, with the growing demand for molecular diagnostics, challenges such as cost, and accessibility need to be addressed. Molecular diagnostics often involve complex laboratory processes and can be expensive. Ensuring affordability and equitable access to these diagnostic tests will be crucial to fully harness their potential in the geriatric population, which may hamper the growth of the market in the forecast period.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on United Kingdom Molecular Diagnostics Market “.

 

The United Kingdom Molecular Diagnostics Market is categorized into Component, Technology, Application, End User, and Company.

In terms of Component, the market is segmented into Instruments, Reagents, Software, and Services. Reagents are projected to experience growth during the forecast period due to their immense necessity for conducting various research measures such as genetic material extraction, protein and biomolecule separation, and genetic material amplification.

Based on technology, the market is categorized into PCR, DNA Sequencing, Hybridization, Microarray, INAAT, and Others. PCR (polymerase chain reaction) is projected to experience growth during the forecast period owing to its rapid amplification of specific DNA segments, facilitating improved diagnosis.

Based on application, the market is segmented into Oncology, Infectious Disease Testing, Genetic Testing, and Others. Infectious Disease Testing is expected to demonstrate growth during the forecast period, driven by the high prevalence of infectious diseases in the United Kingdom.

In terms of end user, the market is divided into Hospitals & Clinics, Diagnostic Laboratories, and Others. The Hospitals & Clinics segment is anticipated to witness growth during the forecast period, attributed to the availability of comprehensive inpatient and outpatient medication facilities, as well as certified healthcare professionals. These factors contribute to the overall growth of the United Kingdom Molecular Diagnostics market.

 

Major companies operating in the United Kingdom Molecular Diagnostics Market are:

  • Johnson & Johnson Services, Inc.
  • Abbott Laboratories Ltd.
  • Siemens Healthineers AG
  • Hologic Inc.
  • Qiagen N.V.
  • Becton, Dickinson and Company Ltd.
  • bioMérieux SA
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The United Kingdom Molecular Diagnostics Market is poised for substantial growth in the coming years, driven by continuous technological advancements in healthcare diagnosis within the nation. The rising healthcare investments and government initiatives for research and innovation will fuel significant market expansion in the United Kingdom. Furthermore, the increasing technological advancements in the medical radiation diagnostics industry and the growing number of hospitals in the nation will further augment the market's growth trajectory, which is expected to continue through 2028,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

United Kingdom Molecular Diagnostics Market By Component (Instruments, Reagents, Software, Services), By Technology (PCR, DNA Sequencing, Hybridization, Microarray, INAAT, Others), By Application (Oncology, Infectious Disease Testing, Genetic Testing, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2018-2028F” has evaluated the future growth potential of the United Kingdom Molecular Diagnostics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the United Kingdom Molecular Diagnostics Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com

Relevant News